We found seven genes equally deregulated in both AR+ TNBC and PRAD (Table 3): CTU and UCN, up-regulated; and CD300LG, KLHL4, PARK2, SCARA5 and SNCG, down-regulated. The gene discussed is AR; the disease is prostate adenocarcinoma.